Cart
sales@molnova.com
GEBR-7b
CAS No. 67387-76-2
GEBR-7b( 3-(Cyclopentyloxy)-4-methoxybenzaldehyde )
Catalog No. M27181 CAS No. 67387-76-2
GEBR-7b is a phosphodiesterase-4 (PDE4) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 33 | In Stock |
|
| 5MG | 28 | In Stock |
|
| 10MG | 43 | In Stock |
|
| 25MG | 73 | In Stock |
|
| 50MG | 107 | In Stock |
|
| 100MG | 160 | In Stock |
|
| 200MG | 241 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGEBR-7b
-
NoteResearch use only, not for human use.
-
Brief DescriptionGEBR-7b is a phosphodiesterase-4 (PDE4) inhibitor.
-
DescriptionGEBR-7b is a phosphodiesterase-4 (PDE4) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms3-(Cyclopentyloxy)-4-methoxybenzaldehyde
-
PathwayAngiogenesis
-
TargetPDE
-
Recptorhuman HEPG2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number67387-76-2
-
Formula Weight220.268
-
Molecular FormulaC13H16O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(C=O)cc1OC1CCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Joerg Kley, et al. Sulfonamides as inhibitors of the uptake of extracellular citrate. Patent WO2018104220A1
molnova catalog
related products
-
Enpp-1-IN-16
Enpp-1-IN-16 is an inhibitor targeting ENPP1 with potential anti-cancer activity.Enpp-1-IN-16 can be used to study insulin resistance in relation to type II diabetes mellitus and various ENPP1-mediated diseases in the chondrocalcinosis and osteoarthritis classes.
-
Ro 20-1724
Ro20-1724 is a widely used inhibitor of cyclic nucleotide phosphodiesterase with IC50 of 2.0 μM and Ki of 3.1 μM.
-
PF-04957325
PF-04957325 is a potent and selective inhibitor of PDE8.PF-04957325 has an IC50 of 0.7 nM for PDE8A and 0.3 nM for PDE8B.PF-04957325 can be used to study autoimmune encephalomyelitis.
